← Open Payments lookup

S. KREPS: Open Payments

NPI 1689728321 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$854 in 24 payments from 8 companies in 2025. Trend: 2023 $1,232 · 2024 $1,229 · 2025 $854

Food & beverage: $854
CompanyPaymentsAmount
ABBVIE INC.12$290
Alkermes, Inc.2$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$122
Teva Pharmaceuticals USA, Inc.1$104
Otsuka America Pharmaceutical, Inc.4$102
Neurocrine BioSciences, Inc.2$40
Otsuka Pharmaceutical Development & Commercialization, Inc.1$30
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: VRAYLAR, LYBALVI, CAPLYTA, REXULTI, INGREZZA, TRINTELLIX, ARISTADA.

Industry payments across PA — which companies pay providers there.